Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Stem Cell Research

Free Subscription Articles published in Oncogene Retrieve available abstracts of 155 articles: HTML format

Single Articles

April 2021
1. ZHOU M, Zhang X, Liu C, Nie D, et al
   Targeting protein lysine methyltransferase G9A impairs self-renewal of chronic myelogenous leukemia stem cells via upregulation of SOX6.
   Oncogene. 2021 Apr 30. pii: 10.1038/s41388-021-01799.
   PubMed     Abstract available
   
   
   March 2021
2. WANG YH, Chan YT, Hung TH, Hung JT, et al
   Transmembrane and coiled-coil domain family 3 (TMCC3) regulates breast cancer stem cell and AKT activation.
   Oncogene. 2021 Mar 19. pii: 10.1038/s41388-021-01729.
   PubMed     Abstract available
   
   
   
3. FUKASAWA K, Kadota T, Horie T, Tokumura K, et al
   CDK8 maintains stemness and tumorigenicity of glioma stem cells by regulating the c-MYC pathway.
   Oncogene. 2021 Mar 16. pii: 10.1038/s41388-021-01745.
   PubMed     Abstract available
   
   
   
4. KERR C, Szmacinski H, Fisher ML, Nance B, et al
   Correction to: Transamidase site-targeted agents alter the conformation of the transglutaminase cancer stem cell survival protein to reduce GTP binding activity and cancer stem cell survival.
   Oncogene. 2021 Mar 3. pii: 10.1038/s41388-021-01709.
   PubMed    
   
   
   
5. SIRKISOON SR, Carpenter RL, Rimkus T, Doheny D, et al
   Correction: TGLI1 transcription factor mediates breast cancer brain metastasis via activating metastasis-initiating cancer stem cells and astrocytes in the tumor microenvironment.
   Oncogene. 2021 Mar 2. pii: 10.1038/s41388-020-01620.
   PubMed    
   
   
   
6. WANG M, Zhao X, Qiu R, Gong Z, et al
   Lymph node metastasis-derived gastric cancer cells educate bone marrow-derived mesenchymal stem cells via YAP signaling activation by exosomal Wnt5a.
   Oncogene. 2021 Mar 2. pii: 10.1038/s41388-021-01722.
   PubMed     Abstract available
   
   
   
7. BIE Q, Song H, Chen X, Yang X, et al
   IL-17B/IL-17RB signaling cascade contributes to self-renewal and tumorigenesis of cancer stem cells by regulating Beclin-1 ubiquitination.
   Oncogene. 2021 Mar 1. pii: 10.1038/s41388-021-01699.
   PubMed     Abstract available
   
   
   February 2021
8. KIM JY, Kim HJ, Jung CW, Choi BI, et al
   Correction: PARK7 maintains the stemness of glioblastoma stem cells by stabilizing epidermal growth factor receptor variant III.
   Oncogene. 2021 Feb 8. pii: 10.1038/s41388-021-01644.
   PubMed    
   
   
   January 2021
9. ZHU P, He F, Hou Y, Tu G, et al
   A novel hypoxic long noncoding RNA KB-1980E6.3 maintains breast cancer stem cell stemness via interacting with IGF2BP1 to facilitate c-Myc mRNA stability.
   Oncogene. 2021 Jan 19. pii: 10.1038/s41388-020-01638.
   PubMed     Abstract available
   
   
   
10. BAI J, Yokomizo-Nakano T, Kubota S, Sun Y, et al
    Overexpression of Hmga2 activates Igf2bp2 and remodels transcriptional program of Tet2-deficient stem cells in myeloid transformation.
    Oncogene. 2021 Jan 15. pii: 10.1038/s41388-020-01629.
    PubMed     Abstract available
    
    
    
11. KIM HJ, Kim JY, Jung CW, Lee YS, et al
    ANO1 regulates the maintenance of stemness in glioblastoma stem cells by stabilizing EGFRvIII.
    Oncogene. 2021 Jan 15. pii: 10.1038/s41388-020-01612.
    PubMed     Abstract available
    
    
    November 2020
12. SARI IN, Yang YG, Wijaya YT, Jun N, et al
    AMD1 is required for the maintenance of leukemic stem cells and promotes chronic myeloid leukemic growth.
    Oncogene. 2020 Nov 17. pii: 10.1038/s41388-020-01547.
    PubMed     Abstract available
    
    
    
13. KIM JY, Kim HJ, Jung CW, Choi BI, et al
    PARK7 maintains the stemness of glioblastoma stem cells by stabilizing epidermal growth factor receptor variant III.
    Oncogene. 2020 Nov 13. pii: 10.1038/s41388-020-01543.
    PubMed     Abstract available
    
    
    October 2020
14. JIA Y, Ding X, Zhou L, Zhang L, et al
    Mesenchymal stem cells-derived exosomal microRNA-139-5p restrains tumorigenesis in bladder cancer by targeting PRC1.
    Oncogene. 2020 Oct 29. pii: 10.1038/s41388-020-01486.
    PubMed     Abstract available
    
    
    
15. YOSHIDA A, Choi J, Jin HR, Li Y, et al
    Fbxl8 suppresses lymphoma growth and hematopoietic transformation through degradation of cyclin D3.
    Oncogene. 2020 Oct 29. pii: 10.1038/s41388-020-01532.
    PubMed     Abstract available
    
    
    
16. NIMMAKAYALA RK, Leon F, Rachagani S, Rauth S, et al
    Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma.
    Oncogene. 2020 Oct 27. pii: 10.1038/s41388-020-01518.
    PubMed     Abstract available
    
    
    
17. ANGEL I, Pilo Kerman O, Rousso-Noori L, Friedmann-Morvinski D, et al
    Tenascin C promotes cancer cell plasticity in mesenchymal glioblastoma.
    Oncogene. 2020 Oct 19. pii: 10.1038/s41388-020-01506.
    PubMed     Abstract available
    
    
    
18. UKAI S, Honma R, Sakamoto N, Yamamoto Y, et al
    Molecular biological analysis of 5-FU-resistant gastric cancer organoids; KHDRBS3 contributes to the attainment of features of cancer stem cell.
    Oncogene. 2020 Oct 12. pii: 10.1038/s41388-020-01492.
    PubMed     Abstract available
    
    
    
19. LATTIER JM, De A, Chen Z, Morales JE, et al
    Megalencephalic leukoencephalopathy with subcortical cysts 1 (MLC1) promotes glioblastoma cell invasion in the brain microenvironment.
    Oncogene. 2020 Oct 10. pii: 10.1038/s41388-020-01503.
    PubMed     Abstract available
    
    
    
20. CHU Y, Chen Y, Guo H, Li M, et al
    SUV39H1 regulates the progression of MLL-AF9-induced acute myeloid leukemia.
    Oncogene. 2020 Oct 9. pii: 10.1038/s41388-020-01495.
    PubMed     Abstract available
    
    
    
21. CHEN Y, Xu L, Lin RY, Muschen M, et al
    Core transcriptional regulatory circuitries in cancer.
    Oncogene. 2020;39:6633-6646.
    PubMed     Abstract available
    
    
    September 2020
22. KARRA L, Romero-Moya D, Ksionda O, Krush M, et al
    Increased baseline RASGRP1 signals enhance stem cell fitness during native hematopoiesis.
    Oncogene. 2020 Sep 28. pii: 10.1038/s41388-020-01469.
    PubMed     Abstract available
    
    
    
23. GAN T, Stevens AT, Xiong X, Wen YA, et al
    Inhibition of protein tyrosine phosphatase receptor type F suppresses Wnt signaling in colorectal cancer.
    Oncogene. 2020 Sep 24. pii: 10.1038/s41388-020-01472.
    PubMed     Abstract available
    
    
    
24. DOHENY D, Sirkisoon S, Carpenter RL, Aguayo NR, et al
    Combined inhibition of JAK2-STAT3 and SMO-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis.
    Oncogene. 2020 Sep 14. pii: 10.1038/s41388-020-01454.
    PubMed     Abstract available
    
    
    August 2020
25. CHI HC, Tsai CY, Wang CS, Yang HY, et al
    DOCK6 promotes chemo- and radioresistance of gastric cancer by modulating WNT/beta-catenin signaling and cancer stem cell traits.
    Oncogene. 2020 Aug 4. pii: 10.1038/s41388-020-01390.
    PubMed     Abstract available
    
    
    July 2020
26. BUSCHHAUS JM, Humphries BA, Eckley SS, Robison TH, et al
    Targeting disseminated estrogen-receptor-positive breast cancer cells in bone marrow.
    Oncogene. 2020 Jul 16. pii: 10.1038/s41388-020-01391.
    PubMed     Abstract available
    
    
    
27. TODA J, Ichii M, Oritani K, Shibayama H, et al
    Signal-transducing adapter protein-1 is required for maintenance of leukemic stem cells in CML.
    Oncogene. 2020 Jul 13. pii: 10.1038/s41388-020-01387.
    PubMed     Abstract available
    
    
    
28. JAMAL SME, Alamodi A, Wahl RU, Grada Z, et al
    Melanoma stem cell maintenance and chemo-resistance are mediated by CD133 signal to PI3K-dependent pathways.
    Oncogene. 2020 Jul 2. pii: 10.1038/s41388-020-1373.
    PubMed     Abstract available
    
    
    
29. CHAI TF, Manu KA, Casey PJ, Wang M, et al
    Isoprenylcysteine carboxylmethyltransferase is required for the impact of mutant KRAS on TAZ protein level and cancer cell self-renewal.
    Oncogene. 2020;39:5373-5389.
    PubMed     Abstract available
    
    
    June 2020
30. LIN CC, Yao CY, Hsu YC, Hou HA, et al
    Knock-out of Hopx disrupts stemness and quiescence of hematopoietic stem cells in mice.
    Oncogene. 2020 Jun 12. pii: 10.1038/s41388-020-1340.
    PubMed     Abstract available
    
    
    
31. PORTNEY BA, Arad M, Gupta A, Brown RA, et al
    ZSCAN4 facilitates chromatin remodeling and promotes the cancer stem cell phenotype.
    Oncogene. 2020 Jun 7. pii: 10.1038/s41388-020-1333.
    PubMed     Abstract available
    
    
    May 2020
32. SIMOES BM, Santiago-Gomez A, Chiodo C, Moreira T, et al
    Targeting STAT3 signaling using stabilised sulforaphane (SFX-01) inhibits endocrine resistant stem-like cells in ER-positive breast cancer.
    Oncogene. 2020 May 30. pii: 10.1038/s41388-020-1335.
    PubMed     Abstract available
    
    
    
33. OKUMURA K, Saito M, Yoshizawa Y, Ito Y, et al
    Pak1 maintains epidermal stem cells by regulating Langerhans cells and is required for skin carcinogenesis.
    Oncogene. 2020 May 19. pii: 10.1038/s41388-020-1323.
    PubMed     Abstract available
    
    
    
34. ZHANG C, Huang S, Zhuang H, Ruan S, et al
    YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation.
    Oncogene. 2020 May 4. pii: 10.1038/s41388-020-1303.
    PubMed     Abstract available
    
    
    
35. SIMON T, Jackson E, Giamas G
    Breaking through the glioblastoma micro-environment via extracellular vesicles.
    Oncogene. 2020 May 4. pii: 10.1038/s41388-020-1308.
    PubMed     Abstract available
    
    
    
36. CAVE DD, Di Guida M, Costa V, Sevillano M, et al
    TGF-beta1 secreted by pancreatic stellate cells promotes stemness and tumourigenicity in pancreatic cancer cells through L1CAM downregulation.
    Oncogene. 2020;39:4271-4285.
    PubMed     Abstract available
    
    
    
37. LARTIGUE L, Merle C, Lagarde P, Delespaul L, et al
    Genome remodeling upon mesenchymal tumor cell fusion contributes to tumor progression and metastatic spread.
    Oncogene. 2020;39:4198-4211.
    PubMed     Abstract available
    
    
    
38. MANJILI MH
    The premise of personalized immunotherapy for cancer dormancy.
    Oncogene. 2020;39:4323-4330.
    PubMed     Abstract available
    
    
    April 2020
39. YIN H, Jiang Z, Feng X, Ji Z, et al
    Identification of Sca-1(+)Abcg1(+) bronchioalveolar epithelial cells as the origin of lung adenocarcinoma in Gprc5a-knockout mouse model through the interaction between lung progenitor AT2 and Lgr5 cells.
    Oncogene. 2020;39:3754-3773.
    PubMed     Abstract available
    
    
    
40. REDONDO MONTE E, Wilding A, Leubolt G, Kerbs P, et al
    ZBTB7A prevents RUNX1-RUNX1T1-dependent clonal expansion of human hematopoietic stem and progenitor cells.
    Oncogene. 2020;39:3195-3205.
    PubMed     Abstract available
    
    
    February 2020
41. YOE J, Kim D, Kim S, Lee Y, et al
    Capicua restricts cancer stem cell-like properties in breast cancer cells.
    Oncogene. 2020 Feb 27. pii: 10.1038/s41388-020-1230.
    PubMed     Abstract available
    
    
    January 2020
42. RICCI B, Millner TO, Pomella N, Zhang X, et al
    Polycomb-mediated repression of EphrinA5 promotes growth and invasion of glioblastoma.
    Oncogene. 2020 Jan 27. pii: 10.1038/s41388-020-1161.
    PubMed     Abstract available
    
    
    
43. MCGINN O, Ward AV, Fettig LM, Riley D, et al
    Cytokeratin 5 alters beta-catenin dynamics in breast cancer cells.
    Oncogene. 2020 Jan 27. pii: 10.1038/s41388-020-1164.
    PubMed     Abstract available
    
    
    
44. CHEN CJ, Yang CJ, Yang SF, Huang MS, et al
    The MyoD family inhibitor domain-containing protein enhances the chemoresistance of cancer stem cells in the epithelial state by increasing beta-catenin activity.
    Oncogene. 2020 Jan 7. pii: 10.1038/s41388-019-1152.
    PubMed     Abstract available
    
    
    
45. SCHAEFER T, Lengerke C
    SOX2 protein biochemistry in stemness, reprogramming, and cancer: the PI3K/AKT/SOX2 axis and beyond.
    Oncogene. 2020;39:278-292.
    PubMed     Abstract available
    
    
    
46. WANG L, Zhao H, Li J, Xu Y, et al
    Identifying functions and prognostic biomarkers of network motifs marked by diverse chromatin states in human cell lines.
    Oncogene. 2020;39:677-689.
    PubMed     Abstract available
    
    
    December 2019
47. HERRMANN A, Lahtz C, Song J, Aftabizadeh M, et al
    Integrin alpha6 signaling induces STAT3-TET3-mediated hydroxymethylation of genes critical for maintenance of glioma stem cells.
    Oncogene. 2019 Dec 9. pii: 10.1038/s41388-019-1134.
    PubMed     Abstract available
    
    
    November 2019
48. DONG KS, Chen Y, Yang G, Liao ZB, et al
    TGF-beta1 accelerates the hepatitis B virus X-induced malignant transformation of hepatic progenitor cells by upregulating miR-199a-3p.
    Oncogene. 2019 Nov 18. pii: 10.1038/s41388-019-1107.
    PubMed     Abstract available
    
    
    
49. CHEN L, De Menna M, Groenewoud A, Thalmann GN, et al
    A NF-kB-Activin A signaling axis enhances prostate cancer metastasis.
    Oncogene. 2019 Nov 18. pii: 10.1038/s41388-019-1103.
    PubMed     Abstract available
    
    
    
50. SHENG YH, Wong KY, Seim I, Wang R, et al
    MUC13 promotes the development of colitis-associated colorectal tumors via beta-catenin activity.
    Oncogene. 2019;38:7294-7310.
    PubMed     Abstract available
    
    
    October 2019
51. KOUZI F, Zibara K, Bourgeais J, Picou F, et al
    Disruption of gap junctions attenuates acute myeloid leukemia chemoresistance induced by bone marrow mesenchymal stromal cells.
    Oncogene. 2019 Oct 24. pii: 10.1038/s41388-019-1069.
    PubMed     Abstract available
    
    
    
52. YANG W, Li Y, Gao R, Xiu Z, et al
    MHC class I dysfunction of glioma stem cells escapes from CTL-mediated immune response via activation of Wnt/beta-catenin signaling pathway.
    Oncogene. 2019 Oct 7. pii: 10.1038/s41388-019-1045.
    PubMed     Abstract available
    
    
    
53. VESCHI V, Mangiapane LR, Nicotra A, Di Franco S, et al
    Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant.
    Oncogene. 2019 Oct 7. pii: 10.1038/s41388-019-1047.
    PubMed     Abstract available
    
    
    
54. TANG K, Yu Y, Zhu L, Xu P, et al
    Hypoxia-reprogrammed tricarboxylic acid cycle promotes the growth of human breast tumorigenic cells.
    Oncogene. 2019;38:6970-6984.
    PubMed     Abstract available
    
    
    
55. HUANG W, Hu H, Zhang Q, Wu X, et al
    Regulatory networks in mechanotransduction reveal key genes in promoting cancer cell stemness and proliferation.
    Oncogene. 2019;38:6818-6834.
    PubMed     Abstract available
    
    
    September 2019
56. LI D, Tian Y, Hu Y, Qi Y, et al
    Correction: Glioma-associated human endothelial cell-derived extracellular vesicles specifically promote the tumourigenicity of glioma stem cells via CD9.
    Oncogene. 2019 Sep 19. pii: 10.1038/s41388-019-1018.
    PubMed     Abstract available
    
    
    
57. SUN J, Yan J, Qiao HY, Zhao FY, et al
    Loss of TRIM29 suppresses cancer stem cell-like characteristics of PDACs via accelerating ISG15 degradation.
    Oncogene. 2019 Sep 9. pii: 10.1038/s41388-019-0992.
    PubMed     Abstract available
    
    
    
58. JI D, Zhang P, Ma W, Fei Y, et al
    Oncogenic heterogeneous nuclear ribonucleoprotein D-like modulates the growth and imatinib response of human chronic myeloid leukemia CD34(+) cells via pre-B-cell leukemia homeobox 1.
    Oncogene. 2019 Sep 5. pii: 10.1038/s41388-019-0998.
    PubMed     Abstract available
    
    
    August 2019
59. SIRKISOON SR, Carpenter RL, Rimkus T, Doheny D, et al
    TGLI1 transcription factor mediates breast cancer brain metastasis via activating metastasis-initiating cancer stem cells and astrocytes in the tumor microenvironment.
    Oncogene. 2019 Aug 28. pii: 10.1038/s41388-019-0959.
    PubMed     Abstract available
    
    
    
60. XU BS, Chen HY, Que Y, Xiao W, et al
    ALK(ATI) interacts with c-Myc and promotes cancer stem cell-like properties in sarcoma.
    Oncogene. 2019 Aug 28. pii: 10.1038/s41388-019-0973.
    PubMed     Abstract available
    
    
    
61. SECKER KA, Keppeler H, Duerr-Stoerzer S, Schmid H, et al
    Inhibition of DOT1L and PRMT5 promote synergistic anti-tumor activity in a human MLL leukemia model induced by CRISPR/Cas9.
    Oncogene. 2019 Aug 15. pii: 10.1038/s41388-019-0937.
    PubMed     Abstract available
    
    
    
62. COOK LM, Frieling JS, Nerlakanti N, McGuire JJ, et al
    Betaglycan drives the mesenchymal stromal cell osteogenic program and prostate cancer-induced osteogenesis.
    Oncogene. 2019 Aug 13. pii: 10.1038/s41388-019-0913.
    PubMed     Abstract available
    
    
    
63. LI D, Tian Y, Hu Y, Qi Y, et al
    Glioma-associated human endothelial cell-derived extracellular vesicles specifically promote the tumourigenicity of glioma stem cells via CD9.
    Oncogene. 2019 Aug 9. pii: 10.1038/s41388-019-0903.
    PubMed     Abstract available
    
    
    
64. THAKUR VS, Aguila B, Brett-Morris A, Creighton CJ, et al
    Spermidine/spermine N1-acetyltransferase 1 is a gene-specific transcriptional regulator that drives brain tumor aggressiveness.
    Oncogene. 2019 Aug 9. pii: 10.1038/s41388-019-0917.
    PubMed     Abstract available
    
    
    
65. BEYES S, Andrieux G, Schrempp M, Aicher D, et al
    Genome-wide mapping of DNA-binding sites identifies stemness-related genes as directly repressed targets of SNAIL1 in colorectal cancer cells.
    Oncogene. 2019 Aug 7. pii: 10.1038/s41388-019-0905.
    PubMed     Abstract available
    
    
    
66. CASLINI C, Hong S, Ban YJ, Chen XS, et al
    HDAC7 regulates histone 3 lysine 27 acetylation and transcriptional activity at super-enhancer-associated genes in breast cancer stem cells.
    Oncogene. 2019 Aug 2. pii: 10.1038/s41388-019-0897.
    PubMed     Abstract available
    
    
    
67. KIM EH, Jo Y, Sai S, Park MJ, et al
    Tumor-treating fields induce autophagy by blocking the Akt2/miR29b axis in glioblastoma cells.
    Oncogene. 2019 Aug 2. pii: 10.1038/s41388-019-0882.
    PubMed     Abstract available
    
    
    July 2019
68. STETKA J, Vyhlidalova P, Lanikova L, Koralkova P, et al
    Addiction to DUSP1 protects JAK2V617F-driven polycythemia vera progenitors against inflammatory stress and DNA damage, allowing chronic proliferation.
    Oncogene. 2019;38:5627-5642.
    PubMed     Abstract available
    
    
    June 2019
69. WANG Z, Kang L, Zhang H, Huang Y, et al
    AKT drives SOX2 overexpression and cancer cell stemness in esophageal cancer by protecting SOX2 from UBR5-mediated degradation.
    Oncogene. 2019;38:5250-5264.
    PubMed     Abstract available
    
    
    
70. BERNAT-PEGUERA A, Simon-Extremera P, da Silva-Diz V, Lopez de Munain M, et al
    PDGFR-induced autocrine SDF-1 signaling in cancer cells promotes metastasis in advanced skin carcinoma.
    Oncogene. 2019;38:5021-5037.
    PubMed     Abstract available
    
    
    
71. TSAI FJ, Lai MT, Cheng J, Chao SC, et al
    Novel K6-K14 keratin fusion enhances cancer stemness and aggressiveness in oral squamous cell carcinoma.
    Oncogene. 2019;38:5113-5126.
    PubMed     Abstract available
    
    
    
72. AASEN T, Leithe E, Graham SV, Kameritsch P, et al
    Connexins in cancer: bridging the gap to the clinic.
    Oncogene. 2019;38:4429-4451.
    PubMed     Abstract available
    
    
    
73. HE W, Liang B, Wang C, Li S, et al
    MSC-regulated lncRNA MACC1-AS1 promotes stemness and chemoresistance through fatty acid oxidation in gastric cancer.
    Oncogene. 2019;38:4637-4654.
    PubMed     Abstract available
    
    
    
74. CHEN C, Bai L, Cao F, Wang S, et al
    Targeting LIN28B reprograms tumor glucose metabolism and acidic microenvironment to suppress cancer stemness and metastasis.
    Oncogene. 2019;38:4527-4539.
    PubMed     Abstract available
    
    
    May 2019
75. TEW BY, Legendre C, Gooden GC, Johnson KN, et al
    Isolation and characterization of patient-derived CNS metastasis-associated stromal cell lines.
    Oncogene. 2019;38:4002-4014.
    PubMed     Abstract available
    
    
    
76. DAI W, Xu X, Wang D, Wu J, et al
    Cancer therapy with a CRISPR-assisted telomerase-activating gene expression system.
    Oncogene. 2019;38:4110-4124.
    PubMed     Abstract available
    
    
    April 2019
77. HU J, Mirshahidi S, Simental A, Lee SC, et al
    Cancer stem cell self-renewal as a therapeutic target in human oral cancer.
    Oncogene. 2019 Apr 1. pii: 10.1038/s41388-019-0800.
    PubMed     Abstract available
    
    
    
78. NISHIMURA T, Nakata A, Chen X, Nishi K, et al
    Cancer stem-like properties and gefitinib resistance are dependent on purine synthetic metabolism mediated by the mitochondrial enzyme MTHFD2.
    Oncogene. 2019;38:2464-2481.
    PubMed     Abstract available
    
    
    March 2019
79. WU M, Sheng L, Cheng M, Zhang H, et al
    Low doses of decitabine improve the chemotherapy efficacy against basal-like bladder cancer by targeting cancer stem cells.
    Oncogene. 2019 Mar 27. pii: 10.1038/s41388-019-0799.
    PubMed     Abstract available
    
    
    
80. WANG L, Zhang Z, Yu X, Huang X, et al
    Unbalanced YAP-SOX9 circuit drives stemness and malignant progression in esophageal squamous cell carcinoma.
    Oncogene. 2019;38:2042-2055.
    PubMed     Abstract available
    
    
    February 2019
81. WANG T, Song P, Zhong T, Wang X, et al
    The inflammatory cytokine IL-6 induces FRA1 deacetylation promoting colorectal cancer stem-like properties.
    Oncogene. 2019 Feb 25. pii: 10.1038/s41388-019-0763.
    PubMed     Abstract available
    
    
    
82. MUNOZ-GALVAN S, Lucena-Cacace A, Perez M, Otero-Albiol D, et al
    Tumor cell-secreted PLD increases tumor stemness by senescence-mediated communication with microenvironment.
    Oncogene. 2019;38:1309-1323.
    PubMed     Abstract available
    
    
    
83. ARIMA K, Ohmuraya M, Miyake K, Koiwa M, et al
    Inhibition of 15-PGDH causes Kras-driven tumor expansion through prostaglandin E2-ALDH1 signaling in the pancreas.
    Oncogene. 2019;38:1211-1224.
    PubMed     Abstract available
    
    
    January 2019
84. CASTAGNOLI L, Cancila V, Cordoba-Romero SL, Faraci S, et al
    WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer.
    Oncogene. 2019 Jan 31. pii: 10.1038/s41388-019-0700.
    PubMed     Abstract available
    
    
    
85. WOOSLEY AN, Dalton AC, Hussey GS, Howley BV, et al
    TGFbeta promotes breast cancer stem cell self-renewal through an ILEI/LIFR signaling axis.
    Oncogene. 2019 Jan 28. pii: 10.1038/s41388-019-0703.
    PubMed     Abstract available
    
    
    
86. ZHOU H, Yu C, Kong L, Xu X, et al
    B591, a novel specific pan-PI3K inhibitor, preferentially targets cancer stem cells.
    Oncogene. 2019 Jan 11. pii: 10.1038/s41388-018-0674.
    PubMed     Abstract available
    
    
    
87. DOMENICI G, Aurrekoetxea-Rodriguez I, Simoes BM, Rabano M, et al
    A Sox2-Sox9 signalling axis maintains human breast luminal progenitor and breast cancer stem cells.
    Oncogene. 2019 Jan 8. pii: 10.1038/s41388-018-0656.
    PubMed     Abstract available
    
    
    
88. GOLD A, Eini L, Nissim-Rafinia M, Viner R, et al
    Spironolactone inhibits the growth of cancer stem cells by impairing DNA damage response.
    Oncogene. 2019 Jan 8. pii: 10.1038/s41388-018-0654.
    PubMed     Abstract available
    
    
    
89. LAU BW, Huh K, Madero-Marroquin R, De Marchi F, et al
    Hedgehog/GLI1 activation leads to leukemic transformation of myelodysplastic syndrome in vivo and GLI1 inhibition results in antitumor activity.
    Oncogene. 2019;38:687-698.
    PubMed     Abstract available
    
    
    
90. CHEN-WICHMANN L, Shvartsman M, Preiss C, Hockings C, et al
    Compatibility of RUNX1/ETO fusion protein modules driving CD34+ human progenitor cell expansion.
    Oncogene. 2019;38:261-272.
    PubMed     Abstract available
    
    
    
91. PATEL Y, Soni M, Awgulewitsch A, Kern MJ, et al
    Overexpression of miR-489 derails mammary hierarchy structure and inhibits HER2/neu-induced tumorigenesis.
    Oncogene. 2019;38:445-453.
    PubMed     Abstract available
    
    
    
92. BAO Y, Guo Y, Yang Y, Wei X, et al
    PRSS8 suppresses colorectal carcinogenesis and metastasis.
    Oncogene. 2019;38:497-517.
    PubMed     Abstract available
    
    
    
93. WENG CH, Chen LY, Lin YC, Shih JY, et al
    Epithelial-mesenchymal transition (EMT) beyond EGFR mutations per se is a common mechanism for acquired resistance to EGFR TKI.
    Oncogene. 2019;38:455-468.
    PubMed     Abstract available
    
    
    December 2018
94. LIU S, Yin P, Kujawa SA, Coon JS 5th, et al
    Progesterone receptor integrates the effects of mutated MED12 and altered DNA methylation to stimulate RANKL expression and stem cell proliferation in uterine leiomyoma.
    Oncogene. 2018 Dec 11. pii: 10.1038/s41388-018-0612.
    PubMed     Abstract available
    
    
    
95. HE Y, Hooker E, Yu EJ, Cunha GR, et al
    Androgen signaling is essential for development of prostate cancer initiated from prostatic basal cells.
    Oncogene. 2018 Dec 3. pii: 10.1038/s41388-018-0583.
    PubMed     Abstract available
    
    
    
96. OHNO Y, Shingyoku S, Miyake S, Tanaka A, et al
    Differential regulation of the sphere formation and maintenance of cancer-initiating cells of malignant mesothelioma via CD44 and ALK4 signaling pathways.
    Oncogene. 2018;37:6357-6367.
    PubMed     Abstract available
    
    
    November 2018
97. WENG CC, Ding PY, Liu YH, Hawse JR, et al
    Mutant Kras-induced upregulation of CD24 enhances prostate cancer stemness and bone metastasis.
    Oncogene. 2018 Nov 22. pii: 10.1038/s41388-018-0575.
    PubMed     Abstract available
    
    
    
98. AN J, Du Y, Fan X, Wang Y, et al
    EGFL6 promotes breast cancer by simultaneously enhancing cancer cell metastasis and stimulating tumor angiogenesis.
    Oncogene. 2018 Nov 19. pii: 10.1038/s41388-018-0565.
    PubMed     Abstract available
    
    
    
99. KUMAR S, Srivastav RK, Wilkes DW, Ross T, et al
    Estrogen-dependent DLL1-mediated Notch signaling promotes luminal breast cancer.
    Oncogene. 2018 Nov 15. pii: 10.1038/s41388-018-0562.
    PubMed     Abstract available
    
    
    
100. HU YB, Yan C, Mu L, Mi YL, et al
     Exosomal Wnt-induced dedifferentiation of colorectal cancer cells contributes to chemotherapy resistance.
     Oncogene. 2018 Nov 2. pii: 10.1038/s41388-018-0557.
     PubMed     Abstract available
     
     
     
101. OOKI A, Dinalankara W, Marchionni L, Tsay JJ, et al
     Epigenetically regulated PAX6 drives cancer cells toward a stem-like state via GLI-SOX2 signaling axis in lung adenocarcinoma.
     Oncogene. 2018;37:5967-5981.
     PubMed     Abstract available
     
     
     October 2018
102. ZEPECKI JP, Snyder KM, Moreno MM, Fajardo E, et al
     Regulation of human glioma cell migration, tumor growth, and stemness gene expression using a Lck targeted inhibitor.
     Oncogene. 2018 Oct 23. pii: 10.1038/s41388-018-0546.
     PubMed     Abstract available
     
     
     
103. BAKHSHINYAN D, Venugopal C, Adile AA, Garg N, et al
     BMI1 is a therapeutic target in recurrent medulloblastoma.
     Oncogene. 2018 Oct 22. pii: 10.1038/s41388-018-0549.
     PubMed     Abstract available
     
     
     
104. SHIMIZU M, Tanaka N
     IL-8-induced O-GlcNAc modification via GLUT3 and GFAT regulates cancer stem cell-like properties in colon and lung cancer cells.
     Oncogene. 2018 Oct 10. pii: 10.1038/s41388-018-0533.
     PubMed     Abstract available
     
     
     
105. LI B, Xu H, Han H, Song S, et al
     Exosome-mediated transfer of lncRUNX2-AS1 from multiple myeloma cells to MSCs contributes to osteogenesis.
     Oncogene. 2018;37:5508-5519.
     PubMed     Abstract available
     
     
     September 2018
106. PAI VC, Hsu CC, Chan TS, Liao WY, et al
     ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-beta-catenin signaling.
     Oncogene. 2018 Sep 28. pii: 10.1038/s41388-018-0497.
     PubMed     Abstract available
     
     
     
107. BALAMURUGAN K, Mendoza-Villanueva D, Sharan S, Summers GH, et al
     C/EBPdelta links IL-6 and HIF-1 signaling to promote breast cancer stem cell-associated phenotypes.
     Oncogene. 2018 Sep 27. pii: 10.1038/s41388-018-0516.
     PubMed     Abstract available
     
     
     
108. CHEN T, Chen J, Zhu Y, Li Y, et al
     CD163, a novel therapeutic target, regulates the proliferation and stemness of glioma cells via casein kinase 2.
     Oncogene. 2018 Sep 26. pii: 10.1038/s41388-018-0515.
     PubMed     Abstract available
     
     
     
109. NAKANO M, Kikushige Y, Miyawaki K, Kunisaki Y, et al
     Dedifferentiation process driven by TGF-beta signaling enhances stem cell properties in human colorectal cancer.
     Oncogene. 2018 Sep 4. pii: 10.1038/s41388-018-0480.
     PubMed     Abstract available
     
     
     
110. GOTO H, Shimono Y, Funakoshi Y, Imamura Y, et al
     Adipose-derived stem cells enhance human breast cancer growth and cancer stem cell-like properties through adipsin.
     Oncogene. 2018 Sep 3. pii: 10.1038/s41388-018-0477.
     PubMed     Abstract available
     
     
     August 2018
111. LEE E, Ouzounova M, Piranlioglu R, Ma MT, et al
     The pleiotropic effects of TNFalpha in breast cancer subtypes is regulated by TNFAIP3/A20.
     Oncogene. 2018 Aug 30. pii: 10.1038/s41388-018-0472.
     PubMed     Abstract available
     
     
     
112. BONETTI P, Climent M, Panebianco F, Tordonato C, et al
     Dual role for miR-34a in the control of early progenitor proliferation and commitment in the mammary gland and in breast cancer.
     Oncogene. 2018 Aug 9. pii: 10.1038/s41388-018-0445.
     PubMed     Abstract available
     
     
     
113. TOSHIYAMA R, Konno M, Eguchi H, Takemoto H, et al
     Poly(ethylene glycol)-poly(lysine) block copolymer-ubenimex conjugate targets aminopeptidase N and exerts an antitumor effect in hepatocellular carcinoma stem cells.
     Oncogene. 2018 Aug 8. pii: 10.1038/s41388-018-0406.
     PubMed     Abstract available
     
     
     
114. LIU Z, Zhang W, Phillips JB, Arora R, et al
     Immunoregulatory protein B7-H3 regulates cancer stem cell enrichment and drug resistance through MVP-mediated MEK activation.
     Oncogene. 2018 Aug 6. pii: 10.1038/s41388-018-0407.
     PubMed     Abstract available
     
     
     
115. MAURIZI G, Verma N, Gadi A, Mansukhani A, et al
     Sox2 is required for tumor development and cancer cell proliferation in osteosarcoma.
     Oncogene. 2018;37:4626-4632.
     PubMed     Abstract available
     
     
     
116. HANDLER J, Cullis J, Avanzi A, Vucic EA, et al
     Pre-neoplastic pancreas cells enter a partially mesenchymal state following transient TGF-beta exposure.
     Oncogene. 2018;37:4334-4342.
     PubMed     Abstract available
     
     
     July 2018
117. LU CH, Yeh DW, Lai CY, Liu YL, et al
     USP17 mediates macrophage-promoted inflammation and stemness in lung cancer cells by regulating TRAF2/TRAF3 complex formation.
     Oncogene. 2018 Jul 23. pii: 10.1038/s41388-018-0411.
     PubMed     Abstract available
     
     
     
118. SHI L, Tang X, Qian M, Liu Z, et al
     A SIRT1-centered circuitry regulates breast cancer stemness and metastasis.
     Oncogene. 2018 Jul 23. pii: 10.1038/s41388-018-0370.
     PubMed     Abstract available
     
     
     
119. LUO L, Tang H, Ling L, Li N, et al
     LINC01638 lncRNA activates MTDH-Twist1 signaling by preventing SPOP-mediated c-Myc degradation in triple-negative breast cancer.
     Oncogene. 2018 Jul 12. pii: 10.1038/s41388-018-0396.
     PubMed     Abstract available
     
     
     
120. JI C, Yang L, Yi W, Xiang D, et al
     Capillary morphogenesis gene 2 maintains gastric cancer stem-like cell phenotype by activating a Wnt/beta-catenin pathway.
     Oncogene. 2018;37:3953-3966.
     PubMed     Abstract available
     
     
     
121. ZIMMERLI D, Cecconi V, Valenta T, Hausmann G, et al
     WNT ligands control initiation and progression of human papillomavirus-driven squamous cell carcinoma.
     Oncogene. 2018;37:3753-3762.
     PubMed     Abstract available
     
     
     May 2018
122. LIAO CP, Lin TP, Li PC, Geary LA, et al
     Loss of MAOA in epithelia inhibits adenocarcinoma development, cell proliferation and cancer stem cells in prostate.
     Oncogene. 2018 May 29. pii: 10.1038/s41388-018-0325.
     PubMed     Abstract available
     
     
     
123. GABBASOV R, Xiao F, Howe CG, Bickel LE, et al
     NEDD9 promotes oncogenic signaling, a stem/mesenchymal gene signature, and aggressive ovarian cancer growth in mice.
     Oncogene. 2018 May 18. pii: 10.1038/s41388-018-0296.
     PubMed     Abstract available
     
     
     
124. GRUN D, Adhikary G, Eckert RL
     NRP-1 interacts with GIPC1 and alpha6/beta4-integrins to increase YAP1/Np63alpha-dependent epidermal cancer stem cell survival.
     Oncogene. 2018 May 14. pii: 10.1038/s41388-018-0290.
     PubMed     Abstract available
     
     
     
125. BAKER A, Wyatt D, Bocchetta M, Li J, et al
     Notch-1-PTEN-ERK1/2 signaling axis promotes HER2+ breast cancer cell proliferation and stem cell survival.
     Oncogene. 2018 May 10. pii: 10.1038/s41388-018-0251.
     PubMed     Abstract available
     
     
     
126. LI N, Zhang Y, Sidlauskas K, Ellis M, et al
     Inhibition of GPR158 by microRNA-449a suppresses neural lineage of glioma stem/progenitor cells and correlates with higher glioma grades.
     Oncogene. 2018 May 3. pii: 10.1038/s41388-018-0277.
     PubMed     Abstract available
     
     
     
127. CHEN A, Sceneay J, Godde N, Kinwel T, et al
     Intermittent hypoxia induces a metastatic phenotype in breast cancer.
     Oncogene. 2018 May 1. pii: 10.1038/s41388-018-0259.
     PubMed     Abstract available
     
     
     
128. TAKAHASHI K, Ehata S, Koinuma D, Morishita Y, et al
     Pancreatic tumor microenvironment confers highly malignant properties on pancreatic cancer cells.
     Oncogene. 2018;37:2757-2772.
     PubMed     Abstract available
     
     
     April 2018
129. TOOSI BM, El Zawily A, Truitt L, Shannon M, et al
     EPHB6 augments both development and drug sensitivity of triple-negative breast cancer tumours.
     Oncogene. 2018 Apr 27. pii: 10.1038/s41388-018-0228.
     PubMed     Abstract available
     
     
     March 2018
130. MONTERISI S, Riso PL, Russo K, Bertalot G, et al
     HOXB7 overexpression in lung cancer is a hallmark of acquired stem-like phenotype.
     Oncogene. 2018 Mar 26. pii: 10.1038/s41388-018-0229.
     PubMed     Abstract available
     
     
     February 2018
131. CAJA L, Tzavlaki K, Dadras MS, Tan EJ, et al
     Snail regulates BMP and TGFbeta pathways to control the differentiation status of glioma-initiating cells.
     Oncogene. 2018 Feb 16. pii: 10.1038/s41388-018-0136.
     PubMed     Abstract available
     
     
     
132. MANCINI R, Noto A, Pisanu ME, De Vitis C, et al
     Metabolic features of cancer stem cells: the emerging role of lipid metabolism.
     Oncogene. 2018 Feb 15. pii: 10.1038/s41388-018-0141.
     PubMed     Abstract available
     
     
     
133. IDOUX-GILLET Y, Nassour M, Lakis E, Bonini F, et al
     Slug/Pcad pathway controls epithelial cell dynamics in mammary gland and breast carcinoma.
     Oncogene. 2018;37:578-588.
     PubMed     Abstract available
     
     
     January 2018
134. AKHTER MZ, Sharawat SK, Kumar V, Kochat V, et al
     Aggressive serous epithelial ovarian cancer is potentially propagated by EpCAM(+)CD45(+) phenotype.
     Oncogene. 2018 Jan 30. pii: 10.1038/s41388-017-0106.
     PubMed     Abstract available
     
     
     
135. O'BRIEN KP, Khan S, Gilligan KE, Zafar H, et al
     Employing mesenchymal stem cells to support tumor-targeted delivery of extracellular vesicle (EV)-encapsulated microRNA-379.
     Oncogene. 2018 Jan 25. pii: 10.1038/s41388-017-0116.
     PubMed     Abstract available
     
     
     
136. SOLOMON H, Dinowitz N, Pateras IS, Cooks T, et al
     Mutant p53 gain of function underlies high expression levels of colorectal cancer stem cells markers.
     Oncogene. 2018 Jan 18. pii: 10.1038/s41388-017-0060.
     PubMed     Abstract available
     
     
     December 2017
137. PENG F, Wang JH, Fan WJ, Meng YT, et al
     Glycolysis gatekeeper PDK1 reprograms breast cancer stem cells under hypoxia.
     Oncogene. 2017 Dec 18. pii: onc2017407. doi: 10.1038/onc.2017.
     PubMed     Abstract available
     
     
     November 2017
138. ALMIRON BONNIN DA, Havrda MC, Lee MC, Liu H, et al
     Secretion-mediated STAT3 activation promotes self-renewal of glioma stem-like cells during hypoxia.
     Oncogene. 2017 Nov 20. doi: 10.1038/onc.2017.
     PubMed     Abstract available
     
     
     
139. PENG F, Wang JH, Fan WJ, Meng YT, et al
     Glycolysis gatekeeper PDK1 reprograms breast cancer stem cells under hypoxia.
     Oncogene. 2017 Nov 6. doi: 10.1038/onc.2017.
     PubMed     Abstract available
     
     
     October 2017
140. DEBEBE A, Medina V, Chen CY, Mahajan IM, et al
     Wnt/beta-catenin activation and macrophage induction during liver cancer development following steatosis.
     Oncogene. 2017;36:6020-6029.
     PubMed     Abstract available
     
     
     
141. OTANI Y, Ichikawa T, Kurozumi K, Inoue S, et al
     Fibroblast growth factor 13 regulates glioma cell invasion and is important for bevacizumab-induced glioma invasion.
     Oncogene. 2017 Oct 23. doi: 10.1038/onc.2017.
     PubMed     Abstract available
     
     
     
142. SIZEMORE GM, Balakrishnan S, Hammer AM, Thies KA, et al
     Stromal PTEN inhibits the expansion of mammary epithelial stem cells through Jagged-1.
     Oncogene. 2017 Oct 16. doi: 10.1038/onc.2017.
     PubMed     Abstract available
     
     
     
143. VISVANATHAN A, Patil V, Arora A, Hegde AS, et al
     Essential role of METTL3-mediated m6A modification in glioma stem-like cells maintenance and radioresistance.
     Oncogene. 2017 Oct 9. doi: 10.1038/onc.2017.
     PubMed     Abstract available
     
     
     
144. WANG CH, Wang PJ, Hsieh YC, Lo S, et al
     Resistin facilitates breast cancer progression via TLR4-mediated induction of mesenchymal phenotypes and stemness properties.
     Oncogene. 2017 Oct 9. doi: 10.1038/onc.2017.
     PubMed     Abstract available
     
     
     September 2017
145. YOUN H, Lee HK, Sohn HR, Park UH, et al
     RaRF confers RA resistance by sequestering RAR to the nucleolus and regulating MCL1 in leukemia cells.
     Oncogene. 2017 Sep 25. doi: 10.1038/onc.2017.
     PubMed     Abstract available
     
     
     
146. WANG F, Wang AY, Chesnelong C, Yang Y, et al
     ING5 activity in self-renewal of glioblastoma stem cells via calcium and follicle stimulating hormone pathways.
     Oncogene. 2017 Sep 18. doi: 10.1038/onc.2017.
     PubMed     Abstract available
     
     
     
147. DEBRUYNE DN, Turchi L, Burel-Vandenbos F, Fareh M, et al
     DOCK4 promotes loss of proliferation in glioblastoma progenitor cells through nuclear beta-catenin accumulation and subsequent miR-302-367 cluster expression.
     Oncogene. 2017 Sep 18. doi: 10.1038/onc.2017.
     PubMed     Abstract available
     
     
     
148. KIM M, Jang K, Miller P, Picon-Ruiz M, et al
     VEGFA links self-renewal and metastasis by inducing Sox2 to repress miR-452, driving Slug.
     Oncogene. 2017;36:5199-5211.
     PubMed     Abstract available
     
     
     August 2017
149. LI XX, Zhang HS, Xu YM, Zhang RJ, et al
     Knockdown of IRE1alpha inhibits colonic tumorigenesis through decreasing beta-catenin and IRE1alpha targeting suppresses colon cancer cells.
     Oncogene. 2017 Aug 21. doi: 10.1038/onc.2017.
     PubMed     Abstract available
     
     
     
150. LI J, Hu SB, Wang LY, Zhang X, et al
     Autophagy-dependent generation of Axin2+ cancer stem-like cells promotes hepatocarcinogenesis in liver cirrhosis.
     Oncogene. 2017 Aug 7. doi: 10.1038/onc.2017.
     PubMed     Abstract available
     
     
     July 2017
151. FETTIG LM, McGinn O, Finlay-Schultz J, LaBarbera DV, et al
     Cross talk between progesterone receptors and retinoic acid receptors in regulation of cytokeratin 5-positive breast cancer cells.
     Oncogene. 2017 Jul 10. doi: 10.1038/onc.2017.
     PubMed     Abstract available
     
     
     June 2017
152. PISTORE C, Giannoni E, Colangelo T, Rizzo F, et al
     DNA methylation variations are required for epithelial-to-mesenchymal transition induced by cancer-associated fibroblasts in prostate cancer cells.
     Oncogene. 2017 Jun 5. doi: 10.1038/onc.2017.
     PubMed     Abstract available
     
     
     
153. SENGUPTA S, Nagalingam A, Muniraj N, Bonner MY, et al
     Activation of tumor suppressor LKB1 by honokiol abrogates cancer stem-like phenotype in breast cancer via inhibition of oncogenic Stat3.
     Oncogene. 2017 Jun 5. doi: 10.1038/onc.2017.
     PubMed     Abstract available
     
     
     
154. PEREZ-ALEA M, McGrail K, Sanchez-Redondo S, Ferrer B, et al
     ALDH1A3 is epigenetically regulated during melanocyte transformation and is a target for melanoma treatment.
     Oncogene. 2017 Jun 5. doi: 10.1038/onc.2017.
     PubMed     Abstract available
     
     
     May 2017
155. RAJA E, Komuro A, Tanabe R, Sakai S, et al
     Bone morphogenetic protein signaling mediated by ALK-2 and DLX2 regulates apoptosis in glioma-initiating cells.
     Oncogene. 2017 May 1. doi: 10.1038/onc.2017.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Stem Cell Research is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: